The Claim
Dexamethasone induces depot-specific expression of genes involved in adipogenesis regulation, with increased DKK2 expression in subcutaneous adipose tissue and increased ENPP2 expression in omental adipose tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Dexamethasone increases DKK2 gene activity in fat under the skin and increases ENPP2 gene activity in fat around the organs, showing that it affects different fat deposits in distinct ways.
See the scientific wording
Dexamethasone induces depot-specific expression of genes involved in adipogenesis regulation, including increased DKK2 in subcutaneous fat and increased ENPP2 in omental fat, suggesting differential control of fat cell development between depots.
Dexamethasone enters fat cells and turns on different genes in belly fat versus under-the-skin fat. In belly fat, it activates genes that promote fat storage and growth, while in under-the-skin fat, it activates genes that help create new fat cells and improve metabolic function. This difference causes each fat depot to develop in its own unique way.
What the research says
1 studyThis study found that dexamethasone changes which genes are active in belly fat versus under-the-skin fat, and those changes suggest the drug affects how each type of fat grows in different ways — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.